(Press-News.org) CHICAGO – Although some data have suggested a possible inverse association between serum vitamin D levels and the incidence of upper respiratory tract infections (colds), participants in a randomized controlled trial who received a monthly dose of 100,000 IUs of vitamin D3 did not have a significantly reduced incidence or severity of colds, according to a study in the October 3 issue of JAMA.
The association of vitamin D insufficiency and susceptibility to viral respiratory tract infections has been unclear, according to background information in the article.
David R. Murdoch, M.D., of the University of Otago, Christchurch, New Zealand, and colleagues conducted a randomized trial to examine the effect of vitamin D supplementation on incidence and severity of upper respiratory tract infections (URTIs) in healthy adults. The study, conducted between February 2010 and November 2011, included 322 healthy adults in New Zealand. Participants were randomly assigned to receive an initial dose of 200,000 IU oral vitamin D3, then 200,000 IU one month later, then 100,000 IU monthly (n = 161), or placebo administered in an identical dosing regimen (n = 161), for a total of 18 months.
The average 25-hydroxyvitamin D (25-OHD) level of participants at the beginning of the study was 29 ng/mL. Vitamin D supplementation resulted in an increase in serum 25-OHD levels that was maintained at greater than 48 ng/mL throughout the study. There were 593 URTI episodes in the vitamin D group and 611 in the placebo group.
The researchers found that there was no statistically significant differences in the number of URTIs per participant (average, 3.7 per person in the vitamin D group and 3.8 per person in the placebo group), duration of symptoms per episode (average, 12 days in each group), number of days of missed work as a result of URTIs, or severity of URTI episodes.
"The main finding from this study is that a monthly dose of 100,000 IU of vitamin D3 in healthy adults did not significantly reduce the incidence or severity of URTIs. This result remained unchanged when the analysis included winter season or baseline 25-OHD levels," the authors write. "Further research is required to clarify whether there is benefit from supplementation in other populations and with other dosing regimens."
###
(JAMA. 2012;308[13]:1333-1339. Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: The study was funded by the Health Research Council of New Zealand. All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.
Please Note: For this study, there will be multimedia content available, including the JAMA Report video, embedded and downloadable video, audio files, text, documents, and related links. This content will be available at 3 p.m. CT Tuesday, October 2 at this link.
Editorial: Vitamin D and the Cure for the Common Cold
Jeffrey A. Linder, M.D., M.P.H., of Brigham and Women's Hospital and Harvard Medical School, Boston, comments on the findings of this study (VIDARIS ) in an accompanying editorial.
"The 2011 IOM report called for additional research to determine whether vitamin D therapy reduces the incidence of respiratory tract infections. The VIDARIS trial has rigorously addressed this question. Results suggest that vitamin D should join the therapies listed in the Cochrane reviews as being ineffective for preventing or treating upper respiratory tract infections in healthy adults."
(JAMA. 2012;308[13]:1375-1376. Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Dr. Linder's work on acute respiratory tract infections is supported by grants from the National Institutes of Health, the National Institute of Allergy and infectious Diseases, and the Agency for Healthcare Research and Quality. The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of interest and none were reported.
To contact David R. Murdoch, M.D., email david.murdoch@otago.ac.nz. To contact editorial author Jeffrey A. Linder, M.D., M.P.H., call Marjorie Montemayor-Quellenberg at 617-534-2208 or email mmontemayor-quellenberg@partners.org.
Vitamin D supplementation does not reduce rate or severity of colds
2012-10-03
ELSE PRESS RELEASES FROM THIS DATE:
Beta-blocker use not associated with lower risk of cardiovascular events
2012-10-03
CHICAGO – Among patients with either coronary artery disease (CAD) risk factors only, known prior heart attack, or known CAD without heart attack, the use of beta-blockers was not associated with a lower risk of a composite of cardiovascular events that included cardiovascular death, nonfatal heart attack or nonfatal stroke, according to a study in the October 3 issue of JAMA.
"Treatment with beta-blockers remains the standard of care for patients with coronary artery disease, especially when they have had a myocardial infarction [MI; heart attack]. The evidence is derived ...
Patients with rheumatoid arthritis appear to be at increased risk for blood clots
2012-10-03
CHICAGO – A study that included more than 45,000 residents of Sweden with rheumatoid arthritis finds that individuals with this disease had an associated higher risk of venous thromboembolism (a blood clot that forms within a vein), and that this elevated risk was stable for 10 years after the time of diagnosis, according to a study in the October 3 issue of JAMA.
"Recent reports suggest that rheumatoid arthritis (RA) may be a risk factor for venous thromboembolism (VTE), particularly in conjunction with hospitalization. Using hospitalization data to identify RA and ...
Cardiac medication may help reduce stiffness caused by certain muscle diseases
2012-10-03
CHICAGO – Preliminary research finds that for patients with nondystrophic myotonias (NDMs), rare diseases that affect the skeletal muscle and cause functionally limiting stiffness and pain, use of the anti-arrhythmic medication mexiletine resulted in improvement in patient-reported stiffness, according to a preliminary study in the October 3 issue of JAMA.
Data on treatment of NDMs are largely anecdotal, consisting of case series and a single-blind, controlled trials of several medications including mexiletine, according to background information in the article.
Jeffrey ...
The genetics of HIV-1 resistance
2012-10-03
Drug resistance is a major problem when treating infections. This problem is multiplied when the infection, like HIV-1, is chronic. New research published in BioMed Central's open access journal Retrovirology has examined the genetic footprint that drug resistance causes in HIV and found compensatory polymorphisms that help the resistant virus to survive.
Currently the strategy used to treat HIV-1 infection is to prevent viral replication, measured by the number of viral particles in the blood, and to repair the immune system, assessed using CD4 count. Over the past 20 ...
Balancing fertility and child survival in the developing world
2012-10-03
Children in smaller families are only slightly more likely to survive childhood in high mortality environments, according to a new study of mothers and children in sub-Saharan Africa seeking to understand why women, even in the highest fertility populations in world, rarely give birth to more than eight children.
The study by Dr David Lawson and Dr Alex Alvergne from UCL Anthropology, and Dr Mhairi Gibson from the University of Bristol, challenges the popular theory proposed by evolutionary anthropologists that natural selection sets the upper limit of high fertility to ...
State-mandated planning, higher resident wealth linked to more sustainable city transportation
2012-10-03
COLUMBUS, Ohio – Transportation practices tend to be more environmentally friendly in wealthier metropolitan areas located within states that mandate comprehensive planning, new research suggests.
The study involved an examination of 225 U.S. metropolitan areas between 1980 and 2008 to gauge how sustainable their transportation practices were and determine what kinds of socioeconomic factors appeared to influence those practices.
Overall, transportation has become less sustainable across the country over this period, but some communities have slowed the decline more ...
Study confirms link between indoor tanning and skin cancer risk
2012-10-03
Indoor tanning increases the risks of developing non-melanoma skin cancer (known as basal cell carcinoma and squamous cell carcinoma), particularly among those exposed before the age of 25, finds a study published on bmj.com today.
It follows a BMJ study published in July that showed 3,438 (5.4%) new cases of melanoma diagnosed each year in Western Europe are related to sunbed use, particularly among young adults.
Some experts are now calling for Europe to follow the example of the United States by introducing a "tan tax" on indoor tanning salons.
The researchers, ...
Doctors speak out about unnecessary care as cost put at $800 billion a year
2012-10-03
Leading doctors are calling for action to tackle unnecessary care that is estimated to account for up to $800bn in the United States every year.
In a special report for this week's BMJ, journalist Jeanne Lenzer describes how a new movement led by prominent doctors is challenging the basic assumption in US healthcare that more is better.
The report comes as an international conference 'Preventing Overdiagnosis' is announced for September 2013 in the United States, hosted by The Dartmouth Institute for Health Policy and Clinical Practice, in partnership with the BMJ, ...
New firework causes severe eye injuries, warn doctors
2012-10-03
A new type of firework caused severe eye injuries and blindness in children and adults at last year's bonfire night celebrations, warn doctors in a letter to this week's BMJ.
Edward Pringle and colleagues describe how on the evening of 5 November 2011, eight patients attended the Sussex Eye Hospital, five with serious eye injuries - two were blinded and the other three have a lifelong glaucoma risk.
Police inquiries suggest the new explosive was derived from "rope banger deer scarers," which have a slow burning rope fuse that ignites several explosives along the rope. ...
Tanning beds linked to non-melanoma skin cancer
2012-10-03
Indoor tanning beds can cause non-melanoma skin cancer – and the risk is greater the earlier one starts tanning, according to a new analysis led by UCSF.
Indoor tanning is already an established risk factor for malignant melanoma, the less common but deadliest form of skin cancer. Now, the new study confirms that indoor tanning significantly increases the risk of non-melanoma skin cancers, the most common human skin cancers.
In the most extensive examination of published findings on the subject, the researchers estimate that indoor tanning is responsible for more ...